A $500 Million Fund to End the Common Cold

The Intercept Foundation is putting up $500 million to develop a single vaccine that could prevent all known strains of the common cold. The money goes toward research and clinical trials aimed at tackling the rhinoviruses and other viruses that cause colds year after year.

The common cold has been stubbornly hard to conquer. Unlike the flu, which changes enough between seasons that a new vaccine each year makes sense, the cold is caused by a family of related viruses that can be tackled together — if the science finally lines up. The Intercept Fund is betting that a broadly protective shot is within reach, and it's putting serious money behind the gamble.

Why this matters for us: the cold costs working families in real dollars and real days missed — and a vaccine that actually sticks could be one of the few health wins that touches every household, not just the ones with good insurance.